Logo image of LXE.CA

Leucrotta Exploration Inc (LXE.CA) Stock Fundamental Analysis

TSX-V:LXE - TSX Venture Exchange - CA52728X2086 - Common Stock

2.21  0 (0%)

Fundamental Rating

3

Overall LXE gets a fundamental rating of 3 out of 10. We evaluated LXE against 210 industry peers in the Oil, Gas & Consumable Fuels industry. The financial health of LXE is average, but there are quite some concerns on its profitability. LXE is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LXE was profitable.
LXE.CA Yearly Net Income VS EBIT VS OCF VS FCFLXE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50M -50M -100M

1.2 Ratios

Industry RankSector Rank
ROA 29.02%
ROE 31.26%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LXE.CA Yearly ROA, ROE, ROICLXE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 20 -20 -40 -60

1.3 Margins

Industry RankSector Rank
OM 29.79%
PM (TTM) 226.9%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LXE.CA Yearly Profit, Operating, Gross MarginsLXE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 200 -200 -400

More info and screens

4

2. Health

2.1 Basic Checks

LXE has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, LXE has an improved debt to assets ratio.
LXE.CA Yearly Shares OutstandingLXE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M
LXE.CA Yearly Total Debt VS Total AssetsLXE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

2.2 Solvency

An Altman-Z score of 14.52 indicates that LXE is not in any danger for bankruptcy at the moment.
A Debt/Equity ratio of 0.00 indicates that LXE is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 14.52
ROIC/WACCN/A
WACCN/A
LXE.CA Yearly LT Debt VS Equity VS FCFLXE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M 200M 300M

2.3 Liquidity

LXE has a Current Ratio of 4.54. This indicates that LXE is financially healthy and has no problem in meeting its short term obligations.
LXE has a Quick Ratio of 4.54. This indicates that LXE is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 4.54
Quick Ratio 4.54
LXE.CA Yearly Current Assets VS Current LiabilitesLXE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M 50M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 501.07% over the past year.
LXE shows a strong growth in Revenue. In the last year, the Revenue has grown by 63.53%.
The Revenue has been growing by 34.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)501.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%357.55%
Revenue 1Y (TTM)63.53%
Revenue growth 3Y2.89%
Revenue growth 5Y34.59%
Sales Q2Q%82.85%

3.2 Future

The Earnings Per Share is expected to decrease by -8.25% on average over the next years.
The Revenue is expected to grow by 91.53% on average over the next years. This is a very strong growth
EPS Next Y-65.67%
EPS Next 2Y-27.32%
EPS Next 3Y-15.53%
EPS Next 5Y-8.25%
Revenue Next Year101.6%
Revenue Next 2Y92.86%
Revenue Next 3Y91.03%
Revenue Next 5Y91.53%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LXE.CA Yearly Revenue VS EstimatesLXE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
LXE.CA Yearly EPS VS EstimatesLXE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 0 0.2 -0.2 -0.4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 5.67 indicates a rather cheap valuation of LXE.
LXE's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.25.
With a Price/Forward Earnings ratio of 10.73, the valuation of LXE can be described as very reasonable.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.80, LXE is valued rather cheaply.
Industry RankSector Rank
PE 5.67
Fwd PE 10.73
LXE.CA Price Earnings VS Forward Price EarningsLXE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 23.76
LXE.CA Per share dataLXE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

LXE's earnings are expected to decrease with -15.53% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-27.32%
EPS Next 3Y-15.53%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LXE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Leucrotta Exploration Inc

TSX-V:LXE (5/31/2022, 7:00:00 PM)

2.21

0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.02%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap551.95M
Analysts83.64
Price Target2.16 (-2.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.67
Fwd PE 10.73
P/S 12.47
P/FCF N/A
P/OCF N/A
P/B 1.72
P/tB N/A
EV/EBITDA 23.76
EPS(TTM)0.39
EY17.65%
EPS(NY)0.21
Fwd EY9.32%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.18
BVpS1.29
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 29.02%
ROE 31.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 29.79%
PM (TTM) 226.9%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.54
Quick Ratio 4.54
Altman-Z 14.52
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)501.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%357.55%
EPS Next Y-65.67%
EPS Next 2Y-27.32%
EPS Next 3Y-15.53%
EPS Next 5Y-8.25%
Revenue 1Y (TTM)63.53%
Revenue growth 3Y2.89%
Revenue growth 5Y34.59%
Sales Q2Q%82.85%
Revenue Next Year101.6%
Revenue Next 2Y92.86%
Revenue Next 3Y91.03%
Revenue Next 5Y91.53%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A